COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?

Antonio Russo, Antonio Galvano, Behzad Baradaran, Oronzo Brunetti, Afshin Derakhshani, Nicola Silvestris

Risultato della ricerca: Articlepeer review

8 Citazioni (Scopus)


The world is facing a new pandemic caused by a novel beta coronavirus (COVID 19), which causes severe respiratory coronavirus syndrome (SARS-CoV-2). Unfortunately, there are currently no US Food and Drug Administration (FDA) approved medications for the treatment of COVID-19 patients. High mortality rates in frail patients is a notable feature of the virus registered since the onset of COVID-19 pandemic. Above all, elderly patients or those with underlying chronic illnesses and compromised immune system are most at risk (1). Thus, the consideration is that the possible coexistence, in the same individual, of a cancer diagnosis and a COVID-19 infection could generate a synergistic negative prognostic effect.
Lingua originaleEnglish
Numero di pagine3
RivistaFrontiers in Oncology
Stato di pubblicazionePublished - 2020

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cita questo